Literature DB >> 15143904

Prognostic factors in esophageal cancer.

Chikara Kunisaki1, Hiroshi Shimada, Hirotoshi Akiyama, Masato Nomura, Goro Matsuda, Hidetaka Ono.   

Abstract

BACKGROUND/AIMS: Despite the advances in surgical treatment and the improvements in perioperative care for esophageal cancer, the long-term prognosis of this disease is poor. To improve long-term survival, it is essential to identify prognostic factors. This paper deals with the prognostic factors in esophageal cancer after potentially curative resection. Furthermore, correlation of the genetic alteration obtained from biopsy specimens with the prognostic factor was determined.
METHODOLOGY: A total of 102 patients, who underwent transthoracic esophagectomy, were retrospectively analyzed. In 18 recent patients, the genetic alteration of E-cadherin, cyclin D1, and p16INK4 were evaluated in the biopsy specimens.
RESULTS: Univariate analysis revealed that the number of metastatic lymph nodes and the tumor diameter significantly influenced prognosis. A Cox proportional regression hazard model showed that only the number of metastatic lymph nodes significantly affected prognosis. Overexpression of E-cadherin and amplification of cyclin D1 was correlated with the number of metastatic lymph nodes but not with p16INK4.
CONCLUSIONS: Preoperative genetic assessment of biopsy specimens obtained endoscopically provides useful information concerning selection of treatment modalities.

Entities:  

Mesh:

Year:  2004        PMID: 15143904

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy.

Authors:  Chikara Kunisaki; Hirochika Makino; Ryo Takagawa; Naoto Yamamoto; Yasuhiko Nagano; Syoichi Fujii; Takashi Kosaka; Hidetaka A Ono; Yuichi Otsuka; Hirotoshi Akiyama; Yasushi Ichikawa; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2007-10-20       Impact factor: 3.452

2.  Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.

Authors:  Xufeng Pan; Teng Mao; Wentao Fang; Wenhu Chen
Journal:  Thorac Cancer       Date:  2014-07-03       Impact factor: 3.500

3.  Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis.

Authors:  Jianming Ying; Ling Shan; Jisheng Li; Lan Zhong; Liyan Xue; Hong Zhao; Lili Li; Cordelia Langford; Lei Guo; Tian Qiu; Ning Lu; Qian Tao
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.